In the BioHarmony Drug Report Database

"Preview" Icon

Nateglinide

Starlix (nateglinide) is a small molecule pharmaceutical. Nateglinide was first approved as Starlix on 2000-12-22. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.

 

Trade Name

 

Starlix
 

Common Name

 

nateglinide
 

ChEMBL ID

 

CHEMBL783
 

Indication

 

type 2 diabetes mellitus
 

Drug Class

 

Antidiabetic, SGLT2 inhibitors, not phlorozin derivatives

Image (chem structure or protein)

Nateglinide structure rendering